PMN vs WST · P/E 4.8, $14.1M cap vs P/E 35, rev $1.72B
ProMIS Neurosciences Inc. (PMN) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
ProMIS Neurosciences Inc. (PMN) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
PMN does not have a complete income-statement cache yet.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
PMN currently screens at market cap $14.1M and trailing P/E 4.8. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the PMN and WST stock pages for the full models.
Not investment advice.